Amy Ware: Structuring Cancer Programs for Enterprise Performance and Accountability
Consultant Amy Ware argues that cancer programs should be structured as integrated enterprises rather than fragmented committees to improve performance. She emphasizes the need for a dedicated executive to align clinical vision with operational and financial strategy.
Why it matters
Effective organizational structure in healthcare is critical for ensuring that patients receive timely access to advanced treatments and clinical trials.
Amy Ware , Principal Consultant at OncoEdge Advisory Partners, shared on LinkedIn :
”I read a piece in JCO Oncology Practice , an American Society of Clinical Oncology ( ASCO ) journal, this week that reinforced something I have seen repeatedly across cancer programs.
We expect cancer programs to perform like enterprises, but rarely structure them like one. Leadership gets spread across dyads, committees, and matrixed reporting, with no single executive accountable for how the whole program performs.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in